Advanced search
1 file | 1.06 MB

Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro

Author
Organization
Keywords
SIPULEUCEL-T, GENERATION, LARGE NUMBERS, TLR9 AGONISTS, PROSTATE-CANCER, CANCER-IMMUNOTHERAPY, GM-CSF, MESSENGER-RNA, CYTOTOXIC T-LYMPHOCYTES, COLONY-STIMULATING FACTOR, Nanoparticle, Cancer vaccination, mRNA, Dendritic cell

Downloads

  • modelsheleen.pdf
    • peer review report
    • |
    • open access
    • |
    • PDF
    • |
    • 1.06 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Dewitte, Heleen, Rein Verbeke, Karine Breckpot, Roosmarijn Vandenbroucke, Claude Libert, Stefaan De Smedt, and Ine Lentacker. 2014. “Choose Your Models Wisely: How Different Murine Bone Marrow-derived Dendritic Cell Protocols Influence the Success of Nanoparticulate Vaccines in Vitro.” Journal of Controlled Release 195: 138–146.
APA
Dewitte, H., Verbeke, R., Breckpot, K., Vandenbroucke, R., Libert, C., De Smedt, S., & Lentacker, I. (2014). Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro. JOURNAL OF CONTROLLED RELEASE, 195, 138–146.
Vancouver
1.
Dewitte H, Verbeke R, Breckpot K, Vandenbroucke R, Libert C, De Smedt S, et al. Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro. JOURNAL OF CONTROLLED RELEASE. 2014;195:138–46.
MLA
Dewitte, Heleen, Rein Verbeke, Karine Breckpot, et al. “Choose Your Models Wisely: How Different Murine Bone Marrow-derived Dendritic Cell Protocols Influence the Success of Nanoparticulate Vaccines in Vitro.” JOURNAL OF CONTROLLED RELEASE 195 (2014): 138–146. Print.
@article{4425954,
  author       = {Dewitte, Heleen and Verbeke, Rein and Breckpot, Karine and Vandenbroucke, Roosmarijn and Libert, Claude and De Smedt, Stefaan and Lentacker, Ine},
  issn         = {0168-3659},
  journal      = {JOURNAL OF CONTROLLED RELEASE},
  keyword      = {SIPULEUCEL-T,GENERATION,LARGE NUMBERS,TLR9 AGONISTS,PROSTATE-CANCER,CANCER-IMMUNOTHERAPY,GM-CSF,MESSENGER-RNA,CYTOTOXIC T-LYMPHOCYTES,COLONY-STIMULATING FACTOR,Nanoparticle,Cancer vaccination,mRNA,Dendritic cell},
  language     = {eng},
  pages        = {138--146},
  title        = {Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro},
  url          = {http://dx.doi.org/10.1016/j.jconrel.2014.06.024},
  volume       = {195},
  year         = {2014},
}

Altmetric
View in Altmetric
Web of Science
Times cited: